Please Wait
Applying Filters...
menu
    • menu
    Chinese FDA-registered generic facilities gain steam, India maintains lead with 396 facilities

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Oct 2024: Lundbeck acquires Longboard for US$ 2.6 bn; molecular glue degrader tech witnesses dealmaking

    Stock Recap
    #PipelineProspector

    Menu

    Remdesivir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,318Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/09/2024 Cambrex Corporation
    U.S.A
    		 Gilead Sciences Korea Ltd. Su205-19-ND Remdesivir 2020-07-24 Cambrex Charles City, Inc U.S.A 1205 11th Street - Charles City, IA 50616, USA
    28/09/2024 Esteve Huayi Pharmaceutical
    China
    		 Gilead Sciences Korea Ltd. Su205-20-ND Remdesivir 2020-07-24 Esteve Huayi Pharmaceutical Co., Ltd. China Linhai Road Shaoxing Paojiang Industrial Zone Yuecheng District Shaoxing Zhejiang 312071 China